Boston Advisors’s Array Biopharma Inc ARRY Stock Holding History

Boston Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-88,336	Closed	-$4.09M	–	652
2019 Q2	$4.09M	Buy	88,336 +11,466	+15%	+$322K	0.22%	126
2019 Q1	$1.87M	Buy	76,870 +21,995	+40%	+$458K	0.1%	240
2018 Q4	$782K	Buy	54,875 +5,715	+12%	+$86.7K	0.05%	375
2018 Q3	$747K	Sell	49,160 -1,105	-2%	-$16.9K	0.03%	423
2018 Q2	$843K	Buy	50,265 +5,385	+12%	+$85.7K	0.02%	415
2018 Q1	$732K	Buy	+44,880	New	+$719K	0.02%	432

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Boston Advisors's ARRY Position: Q3 2019 in Review

Boston Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 88,336 shares — an estimated $4.09M sold.

Boston Advisors first reported a position in ARRY in Q1 2018 and held it in 6 quarters. The position peaked at $4.09M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Boston Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Boston Advisors sold 88,336 Array Biopharma Inc shares in Q3 2019, an estimated $4.09M.
Boston Advisors first reported a position in Array Biopharma Inc in Q1 2018 and held it in 6 quarters.
Boston Advisors's Array Biopharma Inc position peaked at $4.09M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.